Darbepoetin alfa biosimilar (Hallym University Medical Center)
达促红素α生物类似药（Hallym University Medical Center）
Report date: 2023/03/16 20:00:26
Base Information
Drug NameDarbepoetin alfa biosimilar (Hallym University Medical Center)
Drug Alias Name +[10]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesHallym University Medical Center
China Registration ClassN/A
Develop Information
Active CompaniesHallym University Medical Center
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A